findmyKOL
Clinical trialNCT01851265CompletedPhase 1Interventional

D081AC00001 Food Interaction With Olaparib Capsule in Patients With Solid Tumours

SponsorAstraZenecaEnrollment32Solid Tumours
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

7 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Belgium
  • Research Site

    Edegem, Belgium

  • Research Site

    Leuven, Belgium

  • Research Site

    Wilrijk, Belgium

Netherlands
  • Research Site

    Amsterdam, Netherlands

  • Research Site

    Maastricht, Netherlands

United Kingdom
  • Research Site

    Glasgow, United Kingdom

  • Research Site

    Manchester, United Kingdom

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
4 Jul 2013
Primary completion
18 Oct 2013
Completion
6 Jun 2017
Last update posted
28 Aug 2017
Registered enrollment
32
Registry id
NCT01851265

Cross-registrations

EU-CTR / CTIS (EudraCT)2013-001255-13

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.